Skip to main content
Clinical Trials/ACTRN12623000797673
ACTRN12623000797673
Completed
未知

Evaluation of the effectiveness of aromatherapy and music on anxiety, perioperative pain and physiological parameters in adults undergoing extraction of impacted third molars

Ana Rocío García Carricondo0 sites273 target enrollmentJuly 26, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Pain
Sponsor
Ana Rocío García Carricondo
Enrollment
273
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 26, 2023
End Date
September 21, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ana Rocío García Carricondo

Eligibility Criteria

Inclusion Criteria

  • 1\. Adult patients between 18\-50 years of age (age at which the eruption or the pathologies derived from the lack of eruption occures)
  • 2\. Both men and women will be selected
  • 3\. Single procedure per surgical act, that is, only one extraction per patient and episode.
  • 4\. Procedure performed under exclusive local anesthesia.
  • 5\. Patients who agree to participate in the study and sign the Informed Consent form.; 1\. Adult patients between 18\-50 years of age (age at which the eruption or the pathologies derived from the lack of eruption occures)
  • 2\. Both men and women will be selected
  • 3\. Single procedure per surgical act, that is, only one extraction per patient and episode.
  • 4\. Procedure performed under exclusive local anesthesia.
  • 5\. Patients who agree to participate in the study and sign the Informed Consent form.

Exclusion Criteria

  • 1\. Patients under 18 years of age or over 50 years of age.
  • 2\. Multiple procedure, that is, dental polyextraction in the same surgical act.
  • 3\. Patients with deafness or with hearing pathology.
  • 4\. Patients with anosmia or significant loss of smell.
  • 5\. Patients who suffer from epilepsy or have had an epileptic seizure in the last 6 months.
  • 6\. Anticoagulated patients or with bleeding disorders.
  • 7\. Patients undergoing cancer treatment or immunosuppressed.
  • 8\. Patients being treated with bisphosphonates.
  • 9\. Patients with systemic pathology that may interfere with the result.
  • 10\. Patients who have received locoregional radiotherapy.

Outcomes

Primary Outcomes

Not specified

Similar Trials